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Agenda 
 What populations are considered vulnerable? 
 What are the federal regulations associated with 
these populations? 
 What safeguards are suggested? 
 
History 
 World War II Germany: prisoners 
 Twin studies, effects of freezing and overheating, 
effects of high altitude, war wound recovery studies 
in concentration camps 
 Institutionalized population 
Specifically targeted for ease of study 
 Entirely under direction of institution staff 





 Tuskegee: subjugated population 
Syphilis left untreated in impoverished black 
community for 40 years.  Subjects were told they 
were receiving medication. 
 Study not explained to community at large or catered 
to “local research context” 
 Unjust distribution of benefits and burdens amongst 
racial and socioeconomic subpopulations 
 No subject autonomy: deciding according to  
manipulated information 




 Willowbrook State School, NY: cognitively 
impaired minors 
 Institutionalized children made to ingest 
hepatitis contaminants.  Health was monitored; 
no treatment was given. 
 Doubtful capacity for consent; no surrogate 
 Institutionalization taken advantage of 
 Violation of “do no harm” 
 No benefit to outweigh increased risk to minors 
History 
 Lynchburg Institute, VA: “feeble-minded” 
and subjugated 
 Impoverished, delinquent, cognitively impaired 
were institutionalized and involuntarily sterilized 
to “improve” the human gene pool.  Reinforced 
by Supreme Court and Virginia legislation. 
 While not a research study, still a targeting of a 




 Pregnant women, 
fetuses, and IVF 






 Elderly and aged 
 Third parties 
 Minorities 
 International research 
 Healthy volunteers 
 Employees and 
students 
 
The Common Thread 
1. Questionable capacity to consent 
autonomously 
2. Life situation contributing to 
coercion, swayed decision-making 




Consent affected by parental emotion 
1. To insulate children from undue risk 
2. Desperation when confronted with 
hopelessly ill child  
3. To not treat children with procedures only 




From desire to prove pediatric procedures: 
Correction of historical absence from studies. 
Pediatric Research Equity Act (2003) 
 FDA can mandate pediatric trials 
 Safety 
 Efficacy 
 Dosing and regimen 
Justifications for Exclusion (45 CFR 46 Subpart D) 
 It is expected that children will be included in all 
research involving human subjects, unless one or more 
of the following exclusionary circumstances can be fully 
justified:  
Excluding Minors from Adult 
Studies 
1. Topic is irrelevant to children.  
2. Laws or regulations barring the inclusion of children in the 
research. (discussed next)  
3. Knowledge sought in the study is already available or will be 
obtained  
4. A separate, age-specific study in children is warranted and 
preferable.  
5. Insufficient data are available in adults to judge potential risk 
in children.  
6. The study is a continuation of a previous study with pre-
enrolled adults.  
7. Other special cases justified by the investigator and found 
acceptable to the review group and the Institute Director. 
 
45 CFR 46 Subpart D 
Safeguarding Minors 
Consent issues:  
 Minor cannot consent for themselves 
 Parental motive and clarity of decisionmaking 
 Extremely upset 
 Compensation 
Risk to Minors 
Risk Rating  Requirements 
Minimal One parent’s consent 
> Minimal 
Direct benefit 
One parent’s consent 
Risk justified by direct benefit 





Both parents’ consent 
Minor risk increase 
Generalizeable knowledge 
Similar to normal life experiences 
From desire to protect children from undue risk: 
Risk to Minors 
Risk Rating Requirements 
Not otherwise approvable Both parents’ consent 
Generalizeable knowledge 
Approval of  DHHS 
45 CFR 46.404-407  
 
Safeguards for Minors 
 Consent process: 
 Age appropriate assent 
 Adult consent (proportional to risk) 
 Research plan: 
 Expertise of the research team in dealing with children of 
that age 
 Appropriateness of the research facility for children 
 Statistically significant number of children are expected to 
enroll.  
 Compensation: 
 Children: gifts only 
 Parents: Compensation for travel or time lost from work 
Minor Consent 
Missouri Law 
MO Revised Statutes 431.061 
Minors can consent for themselves if: 
 Lawfully married 
 Legal custodian of their or any child 
 In case of: 
(a) Pregnancy, but excluding abortions;  
(b) Venereal disease;  
(c) Drug or substance abuse.  
Minor Consent: Special Situations 
 Accept the minor’s wishes if: 
 Adolescent declining a severely uncomfortable study, and 
they fatally ill 
 Consider an independent consent guardian if: 
 Child abuse is evidenced 
 Transplant is being conducted between minor siblings 
 Wards of the state: Conduct research only in public 
places where most of the children are not wards. 
 
OHRP: IRB Guidebook, 1993. 
Pregnant Women and Fetuses 
Concerns: 
 Risk to the non-consenting 
 Consent from all interested 
parties 
 Poorly motivated termination of 
pregnancy 
 Liability of sponsors and 





Pregnant Women and Fetuses:  
Risk Concerns 
45 CFR 46 Subpart B guides reviewers on the 
following: 
1. Substantial background information about risk 
 Animal, nonpregnant women 
2. If procedure poses risk to fetus … 
 Direct benefit to fetus from that procedure, OR 
 Minimal risk AND only way to obtain information 
Minimal Risk for Fetuses 
No greater risk than that from established 
procedures routinely used in an 
uncomplicated pregnancy or in a 
pregnancy with complications comparable 
to those in study. 
 
OHRP: IRB Guidebook, 1993. 
 
Inclusion of Pregnant and Nursing 
Women 
Inadvertent inclusion in a study including women of 
childbearing potential 
 Provide statement of possible risk to subject or embryo, 
if subject is or becomes pregnant 
 IRBs judge if participation poses risk to fetus or 
nursing infant.  If so: 
 Advise nonpregnant subjects to avoid pregnancy or nursing 
during or following the research 
 Advise nonpregnant subjects to notify the investigator 
immediately should they become pregnant 
 Exclude or study separately 
  OHRP: IRB Guidebook.  1993 
Research directed at maternal health:  
 Maternal needs take precedence over fetal needs, 
except if: 
 Maternal health benefit is minimal, and fetal risk is 
high.  [45 CFR 46.207] 
 IRB review: minimized fetal risk 
 
 
OHRP: IRB Guidebook.  1993. 
Inclusion of Pregnant and Nursing 
Women 
Inclusion of Pregnant and Nursing 
Women 
Studies directed at pregnancy: 
 Study physiological mechanisms; not directed at 
maternal or fetal health 
 Minimized fetal risk 
 
OHRP: IRB Guidebook.  1993. 
 
 
IRBs are responsible for deciding if the study is 
directed at maternal health, fetal health, or 
pregnancy itself. 
Pregnant Women and Fetuses: 
Consent Regulations 
45 CFR 46 Subpart B 
 Maternal consent 
 direct benefit to her, OR her and fetus; 
 No benefit to her or fetus, but risk is minimized and study 
is the only way to gain information. 
 If a minor, can consent for self (emancipated because 
pregnant) 
 Paternal consent 
 Direct benefit only to fetus 
 Unless unavailable, incompetent, mentally incapacitated, or 
guilty of rape/incest 
 Informed of all possible impact on fetus 
 
Termination within a Study 
45 CFR 46 Subpart B 
 The study can provide no inducement to 
terminate 
 Study team may not participate in or advise 
termination 
 Study team may not determine neonate viability 
Pregnant Women and Fetuses: 
Safeguards 
 Waiting Period 
 Repeated Reconsenting 
 Single sheet summaries of key elements 
Cognitively Impaired 
 mental retardation/developmental delay 
 dementia 
 delirium 
 major psychiatric disorders 
 systemic illness 
 other brain diseases 
 some medications 
Cognitively Impaired:  
Recent Problems 
 1991:  T.D. v. New York State Office of Mental Health 
 3 legal advocacy groups sued on behalf of six hospitalized 
psychiatric patients  
 Feared existing regulations might permit investigators to 
enroll them in clinical research inappropriately 
 1994: OPRR investigation  
 suicide of a schizophrenic patient who had recently 
participated in a research trial at the University of California, 
Los Angeles (UCLA) 
 CFR: no specific protections 
 (other than surrogacy) 
Goal for Cognitively Impaired 
 understand the nature of the research 
 understand participation 
 appreciate the consequences of 
participation 
 consider alternatives 
 make a reasoned choice 
 feel free from coercive pressure of 
institutionalized lifestyle 
Cognitively Impaired 
Question: Does the disorder or impairment 
affect ability to achieve consent goals? 
 
Not always. 
Assessment of Understanding 
 individualized  
 open-ended 
 elements presented individually 
 oral and written 
 4th to 6th grade 
 
On HSC website. 
 
Cognitively Impaired:  
Consent Safeguards 
 Conduct research only if related to impairment 
 Early identification of surrogate 
 Consent with surrogate’s “duplicate” consent, OR 
assent with surrogate’s consent 
 Reconsenting 
 more critical in higher risk protocols 
 Advance Directive 




Missouri Revised Statutes 431.064  gives order 
of surrogacy: 
(1) Spouse unless the patient has no spouse, or is 
separated, or the spouse is physically or mentally 
incapable of giving consent, or the spouse's 
whereabouts is unknown or the spouse is 
overseas;  
(2) Adult child;  
(3) Parent;  
(4) Brother or sister;  
(5) Relative by blood or marriage.  
Cognitive Impairment 
References 
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Prisoners 
45 CFR part 46.303(c) 
"any individual involuntarily confined or detained 
in a penal institution.” 
 sentenced under a criminal or civil statute 
 detained in alternatives to criminal prosecution or 
incarceration in a penal institution 
 detained pending arraignment, trial, or sentencing  
Prisoners 
Concerns: 
 Coercive environment 
 Perceived ability to improve environment through 
study participation 
 Risk of loss of confidentiality of participation, of data 
 Prisoner movement 
 Records 
 
Included if were prisoners at time of enrollment or 
entered prison after enrollment. 
Prisoner Protocols:  
IRB Committee Requirements 
 Majority shall have no affiliation to prison(s) 
involved 
 One member shall be a prisoner or 
appropriate prisoner representative 
 
Permissible Prisoner Protocols 
45 CFR 46.306(a)(2) 
1. possible causes, effects, and processes of 
incarceration, and of criminal behavior 
 No more than minimal risk and inconvenience 
2. prisons as institutional structures or of prisoners as 
incarcerated persons 
 No more than minimal risk and inconvenience 
3. conditions particularly affecting prisoners 
 Hepatitis, AIDS 
 Social and psychological problems 
 Federal consultation 
4. intent and reasonable probability of direct subject 
benefit 
 Non-beneficial control arms: federal consultation. 
Prisoner Safeguards 
45 CFR 46.305(a) 
Benefits: not coercive 
Risks: would be accepted by nonprisoner volunteers 
Subject selection: random from eligible pool 
 Fair to all prisoners 
 No arbitrary intervention by prison authorities or prisoners 
Consent:  
 Understandable language 
 Participation not included in parole deliberation 
 Follow-up procedure accounts for varying length of 
sentences 
Severely Ill 
Includes: Traumatized, comatose, ICU patients,  dying 
Concerns: 
 Ability to consent hampered 
 Strong painkillers 
 Unconsciousness or delirium 
 Limited time for consenting or contacting surrogates 
 Coercive feeling of desperation 
 Designation of surrogate 
 Same MO laws apply as for cognitive impairment 
Emergency Consent of the 
Traumatized 
Exception from informed consent permitted when: 
1. situation is life threatening, and necessitates the use of 
the test article;  
2. informed consent cannot be obtained because of an 
inability to communicate with, or obtain legally effective 
consent;  
3. there is not sufficient time to obtain consent from the 
subject's legally authorized representative; and  
4. there is no alternative method of approved or generally 
recognized therapy that provides an equal or greater 
likelihood of saving the life of the subject available. 
 
Emergency Consent of the 
Traumatized (cont’d) 
5. Study may be of direct benefit to participant. 
6. Notice of involvement and follow-up information 
to patient and family will be provided as soon as 
possible. 
7. Community involvement. 
 
HSC Guideline for Emergency Research 
 
Consent at End Of Life 
2001 study: quality of informed consent 
 Competence not always measured 
 In majority of cases, ability to consent was inferred 
from dementia, delirium noted in medical chart 
Allan S. Brett, MD; Jason C. Rosenberg, MD. The Adequacy of Informed Consent 
for Placement of Gastrostomy Tubes Arch Intern Med. 2001;161:745-748. 
 
It is obviously preferable for the investigative team to 
assess competency for consent. 
 (HSC Assessment for Understanding) 
 
Safeguards for the Severely Ill 
 Advance Directive 
 During time of lucidity 
 Early designation of surrogate 
 Independent monitor 
 Documentation: consent process, lucidity cycles 
 Progress of research 
 Physician not act as PI  
 Readily available emergency services 
Considerations for Protocols 
Including the Severely Ill 
 anticipated toxicity of the therapeutic 
interventions;  
 extent to which subjects are likely to be 
debilitated by either their illness or their therapy; 
  the remaining life expectancy of the subjects;  
 whether participation in the research would 
require a change in residence (e.g., from home or 
hospice to a hospital or research institution).  
Elderly and Aged 
 Concerns:  
 cognitive impairment  
 institutionalization  
 Consenting with hearing or vision problems 
Safeguards for the Elderly and Aged 
 If institutionalized: Avoid this population unless 
research is on institutionalization.   
 Consent forms in larger font 
 Assessment of understanding 
 






 Private, identifiable information is obtained 




 Third party will feel coerced to participate by 
their family member’s participation being linked 
to their own 




Consenting Third Parties 
Initial contact should always be made by the 
primary subject. 
 Letter to primary subject: 
 Explanation of research and the role of the family 
member in the study  
 Description of information to be obtained 
 Card with self-addressed, stamped envelope so 
family member can grant permission 
 NOT acceptable for PI to obtain names/addresses 
of family members in order to contact them for 
consent to participate. 
Consenting Third Parties 
Waiver of consent: (45 CFR 46.117 (d) (1-4)) 
 no more than minimal risk; 
 the waiver will not adversely affect subjects’ 
rights and welfare; 
 the research could not practicably be carried 
out without the waiver; and 
 whenever appropriate, subjects will be 
provided with follow-up information 
Healthy Volunteers 
Concerns: 
 Motive for participation 
 Altruism?? 
 Compensation 
 Personal risk/benefit ratio 
 “Do Not Harm” 
 Maximize benefit, minimize harm 
Safeguards for Healthy Volunteers 
Compensation:  Not coercive 
Participant pool: 
1. participants with a permanent address 
2. participants with a source of income 
3. independent monitor 
4. ask potential subjects about previous clinical trial 
experience (avoid enrollment of “career 
participants”)  
 Particularly important for very uncomfortable or 
dangerous studies 
Employees and Students 
Concerns: 
 Desire to please 
 Relationship to investigative team 
 Security 
 Frequent target of recruitment 
 Confidentiality 
 
Employees and Students: 
Safeguards 
Recruitment:  
 Avoid involvement of personal relationship. 
 general announcements or advertisements, rather than 
individual solicitations 
 Avoid involvement of professional ambition. 
 If study participation is offered for class credit, other options 
should be given 
 Research paper (ungraded) 
 Attendance at faculty colloquia (merely show up) 
 If students do choose to participate in studies, they should be 
given several studies from which to choose. 
Employees and Students: 
Confidentiality 
Working within research environment: increased 
risk of disclosure  
 Safeguards: 
 Limiting identifying information 
 Codes or encryption 
 Limited access to information 
 Information kept only for a specific length of time 
 Staff statement of confidentiality 
 
Minorities 
Based on statistical alignment of minority status with 
lower socioeconomic status … 
Concerns: 
 Under representation by recruitment through health 
care insurers 
 Under representation due to difficulty of recruitment 
 Coercion through monetary compensation 
 Literacy, cultural norms, and informed consent 
 Paternalism and stereotyping 
 
Safeguards for Minorities 
 Thinking outside the box for recruitment 
 Through community centers, rather than health care 
providers 
 Provision of child care and transportation 
 Consent documents adjusted for language 
barriers and cultural norms 
 
OHRP: IRB Guidebook.  1993. 
 
Summary 
 “vulnerable population”: life circumstance 
contributing to coercion or inability to consent 
 Safeguards: prolonged or reinforced informed 
consent, protected confidentiality 
 HSC guidance  (www.medicine.wustl.edu/hsc) 
 Federal regulations  
 45 CFR 46, Subparts A-D 
 OHRP IRB Guidebook, Chapter 6 
Final Recommendations 
Anyone can be “vulnerable”, if a life experience 
causes their consenting ability for a given study 
to be minimized. 
 
Always consider possible safeguards. 
